689 related articles for article (PubMed ID: 27913996)
81. The improvement of nonalcoholic steatohepatitis by Poria cocos polysaccharides associated with gut microbiota and NF-κB/CCL3/CCR1 axis.
Tan YY; Yue SR; Lu AP; Zhang L; Ji G; Liu BC; Wang RR
Phytomedicine; 2022 Aug; 103():154208. PubMed ID: 35691078
[TBL] [Abstract][Full Text] [Related]
82. Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis.
Yoshimine Y; Uto H; Kumagai K; Mawatari S; Arima S; Ibusuki R; Mera K; Nosaki T; Kanmura S; Numata M; Tamai T; Moriuchi A; Tsubouchi H; Ido A
Oncol Rep; 2015 Apr; 33(4):1657-66. PubMed ID: 25607821
[TBL] [Abstract][Full Text] [Related]
83. Obesity, fatty liver disease and intestinal microbiota.
Arslan N
World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
[TBL] [Abstract][Full Text] [Related]
84. Artemisia sphaerocephala Krasch polysaccharide prevents hepatic steatosis in high fructose-fed mice associated with changes in the gut microbiota.
Zhang B; Ren D; Zhao Y; Liu Y; Zhai X; Yang X
Food Funct; 2019 Dec; 10(12):8137-8148. PubMed ID: 31746883
[TBL] [Abstract][Full Text] [Related]
85. Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model.
Okubo H; Sakoda H; Kushiyama A; Fujishiro M; Nakatsu Y; Fukushima T; Matsunaga Y; Kamata H; Asahara T; Yoshida Y; Chonan O; Iwashita M; Nishimura F; Asano T
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G911-8. PubMed ID: 24113768
[TBL] [Abstract][Full Text] [Related]
86. Dietary glycotoxins exacerbate progression of experimental fatty liver disease.
Leung C; Herath CB; Jia Z; Goodwin M; Mak KY; Watt MJ; Forbes JM; Angus PW
J Hepatol; 2014 Apr; 60(4):832-8. PubMed ID: 24316518
[TBL] [Abstract][Full Text] [Related]
87. High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice.
Xiao L; Sonne SB; Feng Q; Chen N; Xia Z; Li X; Fang Z; Zhang D; Fjære E; Midtbø LK; Derrien M; Hugenholtz F; Tang L; Li J; Zhang J; Liu C; Hao Q; Vogel UB; Mortensen A; Kleerebezem M; Licht TR; Yang H; Wang J; Li Y; Arumugam M; Wang J; Madsen L; Kristiansen K
Microbiome; 2017 Apr; 5(1):43. PubMed ID: 28390422
[TBL] [Abstract][Full Text] [Related]
88. Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease
Xing YW; Lei GT; Wu QH; Jiang Y; Huang MX
World J Gastroenterol; 2019 Feb; 25(8):955-966. PubMed ID: 30833801
[TBL] [Abstract][Full Text] [Related]
89. Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis.
Pierce AA; Pickens MK; Siao K; Grenert JP; Maher JJ
BMC Gastroenterol; 2015 Jun; 15():72. PubMed ID: 26103964
[TBL] [Abstract][Full Text] [Related]
90. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites.
Zhu M; Wang X; Wang K; Zhao Z; Dang Y; Ji G; Li F; Zhou W
Front Cell Infect Microbiol; 2023; 13():1066053. PubMed ID: 36779187
[TBL] [Abstract][Full Text] [Related]
91. Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.
Kammoun HL; Allen TL; Henstridge DC; Kraakman MJ; Peijs L; Rose-John S; Febbraio MA
PLoS One; 2017; 12(6):e0179099. PubMed ID: 28632778
[TBL] [Abstract][Full Text] [Related]
92. Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet.
Zeng H; Larson KJ; Cheng WH; Bukowski MR; Safratowich BD; Liu Z; Hakkak R
J Nutr Biochem; 2020 Apr; 78():108336. PubMed ID: 32004929
[TBL] [Abstract][Full Text] [Related]
93. Assessment of hepatic fatty acids during non-alcoholic steatohepatitis progression using magnetic resonance spectroscopy.
Xavier A; Zacconi F; Santana-Romo F; Eykyn TR; Lavin B; Phinikaridou A; Botnar R; Uribe S; Oyarzún JE; Cabrera D; Arrese M; Andia ME
Ann Hepatol; 2021; 25():100358. PubMed ID: 33962045
[TBL] [Abstract][Full Text] [Related]
94. Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice.
Zhang Z; Chen X; Cui B
Food Funct; 2021 May; 12(10):4504-4518. PubMed ID: 33885128
[TBL] [Abstract][Full Text] [Related]
95. Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice.
Blasco-Baque V; Coupé B; Fabre A; Handgraaf S; Gourdy P; Arnal JF; Courtney M; Schuster-Klein C; Guardiola B; Tercé F; Burcelin R; Serino M
Diabetologia; 2017 Apr; 60(4):690-700. PubMed ID: 28105518
[TBL] [Abstract][Full Text] [Related]
96. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
[TBL] [Abstract][Full Text] [Related]
97. Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids.
Janssen AWF; Houben T; Katiraei S; Dijk W; Boutens L; van der Bolt N; Wang Z; Brown JM; Hazen SL; Mandard S; Shiri-Sverdlov R; Kuipers F; Willems van Dijk K; Vervoort J; Stienstra R; Hooiveld GJEJ; Kersten S
J Lipid Res; 2017 Jul; 58(7):1399-1416. PubMed ID: 28533304
[TBL] [Abstract][Full Text] [Related]
98. The Ameliorating Effects of n-3 Polyunsaturated Fatty Acids on Liver Steatosis Induced by a High-Fat Methionine Choline-Deficient Diet in Mice.
Šmíd V; Dvořák K; Stehnová K; Strnad H; Rubert J; Stříteský J; Staňková B; Stránská M; Hajšlová J; Brůha R; Vítek L
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139055
[TBL] [Abstract][Full Text] [Related]
99. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
[TBL] [Abstract][Full Text] [Related]
100. Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model.
Kishida Y; Okubo H; Ohno H; Oki K; Yoneda M
J Gastroenterol; 2017 Nov; 52(11):1180-1191. PubMed ID: 28349245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
